بلاگ
A literature review on the imaging methods for breast cancer

Abstract
Breast cancer will be easier and more effective to treat if detected early. Breast cancer is assessed and detected using imaging as a primary approach. The capacity to diagnose breast cancers is continually improving thanks to developments in imaging technologies. However, some of these enhancements have been linked to delays in the initiation of treatment procedures of breast cancer. Overall, cancer management relies heavily on imaging procedures such as screening and symptomatic disease management. Mammography, which is considered the gold standard, and breast ultrasonography are employed as routine imaging modalities. Previous research has shown that, despite recent developments, no single imaging modality can detect and characterizing majority of breast lesions. Various imaging methods and their uses in diagnosing and caring the breast cancer are discussed in this study.
Introduction
Cancer is one of the non-communicable diseases, which causes high mortality rates worldwide, accounting for 12% of all fatalities, with around 12 million new cases diagnosed each year [1,2]. This cancer is responsible for almost 24.2% of new cancers in females [3]. Breast cancer would account for 11.7 percent of all cancer cases in 2025, with an estimated 2.3 million new cases in women, surpassing pulmonary cancer as the main cause of global cancer incidence [4,5]. According to a survey of the literature, there were approximately two million new cases of breast cancer and 626,679 fatalities reported in 2018 [6]. This cancer could also harm women with younger ages [7]. In comparison to other races, Iranian women have a larger breast density [8,9]. According to surveys, 90 percent of females with breast cancer survive; however, for women with advanced disease, the survival rate reduces to 60 percent [10]. Despite the adoption of harsh medicines in recent years, fatality rates have remained high, prompting greater research into new cancer treatment options [11,12]. Imaging is used in all stages of neoplasm treatment [13]. Imaging technologies, which are a key part of cancer clinical procedures, are the first step in diagnosing the disease [14]. Medical imaging has a number of advantages, including real-time monitoring without tissue loss, long-term usage, and a less invasive process [11]. In a literature review, Leonard Fass (2008) and Safarpour Lima and colleagues (2019) found that cancer care is dependent on imaging through screening [11,14]. Breast cancer can be detected early using imaging tools [6]. The sensitivity and specificity of various techniques, however, vary [15,16]. Integrated imaging techniques, according to evaluations, can provide additional data about the disease managemen [11]. Complementary imaging includes screening mammography, ultrasonography, and a mixture of these procedures [14]. Additional screening modalities, such as ultrasonography, are recommended for women with thick breast tissue due to an increase in false-negative mammography [17]. Combining the screening ultrasound with mammography, according to Berg and colleagues (2008), will lead to a significant decrease in diagnosis of cases, but will also vastly enhance the number of false positives [18].
Diagnostics will be enhanced by combining many imaging modalities [19]. This article discusses new scientific methods for analyzing, diagnosing, and evaluating benign and aggressive breast cancer.
Imaging techniques
Because of changes in physical qualities, images produced by imaging instruments show differences in contrast. Digital imaging technologies are gaining significant attention of X-ray-based techniques in cancer imaging. A magnetic resonance system is used to detect cancer, stage it, assess therapy response and guide biopsy procedures [14].
Digital imaging technology
Mammography is a common screening tool [20]. Mammography screening for malignancy is commonly used to detect the disease [7]. It is reported in multiple studies to help decrease cancer death rates [7,21]. Although mammography can be used to imaging young, compact breasts, it is insufficiently sensitive to detect lesions since the surrounding fibro glandular tissue obscures lesions’ appearance [11]. Mammography on film is the “gold standard” of detecting breast neoplasm [22]. Though it can also be used for early identification and follow-up of tumors [7], does have some inherent limitations, such as screen-film mammography’s limitations, poor contrast features [23]. Full-field digital mammography (FFDM) is a useful imaging method for breast screening that offers a number of benefits over traditional film-based treatments. Reduced dose, telemedicine, softcopy review, tomosynthesis and digital archiving are just a few of the advantages [14]. It’s worth noting that traditional film-screen mammography has cost and availability benefits [24].
In a research named “Screen-Film Mammography versus Full-Field Digital Mammography with Soft-Copy Reading”, Skaane and Skjennald (2004) found that mammography had a greater cancer detection results than screen-film mammography in the 50-69 age category. The detection rates for the two systems were nearly identical in the 45-49 age group [25]. In a study, Obenauer and colleagues found that digital mammography has high image quality compared to screen film [26]. The overlaying and concealing of cancers by normal tissues such as glandular tissue is one of the potential limitations of 2D mammography [11]. Using X-ray equipment could help to minimize breast tightness [14]. Iodinated agents are used in contrast-enhanced mammography as an exploratory approach [27]. This experimental technology is based on the idea that rapid tumor growth necessitates increased blood supply via angiogenesis [13]. Contrast must be supplied if the compression tool is not active. The contrast agent will accumulate in angiogenesis sites [27]. Tomosynthesis may be useful for diagnosing primary and secondary lesions as well as monitoring therapy [11,28].
Ultrasonography
Breast cancer is diagnosed via ultrasonography, which is a standard imaging procedure. In recent years, it has advanced to the point that it can now be used for breast imaging [7]. Ultrasound is a technology used as a follow-up examination to clarify equivocal findings [29]. In primarily fatty breasts and dense breasts, ultrasonography can be used to assess the orientation and morphology [30]. A panoramic high-resolution image of the breast is obtained using extended field of view imaging [31,32]. Elastic sonography is a typical approach for detecting breast lesions using ultrasonic detection [33]. Ultrasound with contrast is used to detect and monitor the progress of local treatment [34]. Intravenously injected gas microbubbles are used in this approach [35]. The volume of a lesion can be calculated using 3D ultrasonography [36].
Even though some researchers believed that using ultrasonography to detect cases missed by mammography would increase the number of false-positive masses [37]. Berg and colleagues (2008) found that employing ultrasonography in conjunction to mammography improved diagnosis accuracy [18]. When comparing mammography with ultrasound findings, one study discovered that mammography is recommended for breast cancer [38]. In a 2008 report, it was discovered that screening ultrasound can detect tiny, node-negative breast tumors [18]. Finally, the scientists found that clinical diagnosis, ultrasonography, and mammography could predict breast neoplasm [39]. In another survey that was conducted by Devolli-Disha and colleagues, they evaluated 546 women with breast complaints and discovered that ultrasonography had a statistically significant higher than mammography in patients with breast complaints [40].
Magnetic resonance imaging (MRI)
Breast MRI is used in conjunction with mammography as a support tool [11]. Ross and colleagues (1982) employed MRI to examine breast neoplasm [41]. Breast MR is gradually gaining acceptance as a supplementary tool. Although MRI has a greater sensitivity than mammography, it is not frequently utilized as a breast cancer surveillance test due to high false positives and high costs [42]. Breast MRI is a beneficial method for screening in women who have dense breast tissue [11]. The American Cancer Society has validated that MRI can detect contralateral breast neoplasm extension [11]. Because of these issues, MRI looks to be preferred to mammography [43]. This discrepancy suggests that magnetic resonance imaging can be helpful in deciding whether to have a breast-conserving mastectomy or surgery. Recent advances in MRI technologies has enabled more accurate cancer detection and anatomical delineation [44,45].
Some research suggest using a combination of approaches to detect breast cancer early [15]. According to a study, mammography alone, as well as mammography and ultrasonography, is not sufficient for early diagnosis [46]. Table 1 presents and compares the sensitivity and specificity values of imaging methods.
Table 1.
Comparison of sensitivity and specificity of imaging technologies in breast cancer1
| First author (year) | M | US | MRI | Ref. | |||
|---|---|---|---|---|---|---|---|
| SE (%) | SP (%) | SE (%) | SP (%) | SE (%) | SP (%) | ||
| Kuhl (2000) | 33.0 | 30.0 | 33.0 | 12.0 | 100.0 | 64.0 | [47] |
| Warner (2001) | 33.0 | – | 60.0 | – | 100.0 | – | [48] |
| Berg (2004) | 67.8 | 75.0 | 83.0 | 34.0 | 94.4 | 26.0 | [49] |
| Kuhl (2005) | 32.6 | 96.8 | 39.5 | 90.5 | 90.7 | 97.2 | [46] |
| Warner (2008) | 32.0 | 94.7 | – | – | 75.0 | 96.1 | [50] |
| Sardanelli (2011) | 50.0 | 99.0 | 52.0 | 98.4 | 91.0 | 96.7 | [51] |
| Lehman (2012) | 61 | 94 | 96 | 89 | – | – | [52] |
| Tan (2014) | 49 | 89 | 82 | 84 | – | – | [53] |
| Song (2015) | 66.7 | 89.5 | 83.3 | 71.1 | 100.0 | 61.8 | [54] |
| Berg (2016) | 53 | 90 | 52 | 86 | – | – | [55] |
| Omidiji (2017) | 86 | 56 | 89 | 22 | – | – | [56] |
M: Mammography; US: Ultrasonography; MRI: Magnetic resonance imaging; SE: Sensitivity; SP: Specificity.
Conclusion
Early diagnosis of breast cancer is likely the most important factor in cancer fatality reduction and is critical for successful treatment. Breast screening aims to discover cancer early, when therapy is more likely. Imaging techniques are currently used to diagnose breast cancer. However, due to existing imaging technologies’ low sensitivity and specificity, demand for new imaging techniques has grown in the diagnosis of this disease.
Disclosure of conflict of interest
None.
References
- 1.Haddad S, Ghadimi K, Abrishamkar R, Asl NS. Comparing laparoscopy and laparotomy procedures in the radical hysterectomy surgery for endometrial cancer: a basic review. Am J Transl Res. 2021;13:2456. [PMC free article] [PubMed] [Google Scholar]
- 2.Ratanachaikanont T. Clinical breast examination and its relevance to diagnosis of palpable breast lesion. J Med Assoc Thai. 2005;88:505–507. [PubMed] [Google Scholar]
- 3.Samani RE, Ebrahimi H, Zadeh AR, Safaee M. Evaluation of relative abundance of lymphedema after reverse axillary mapping in patients with breast cancer. Adv Biomed Res. 2022;11:36. doi: 10.4103/abr.abr_281_21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
- 5.Peairs KS, Choi Y, Stewart RW, Sateia HF. Screening for breast cancer. Semin Oncol. 2017;44:60–72. doi: 10.1053/j.seminoncol.2017.02.004. [DOI] [PubMed] [Google Scholar]
- 6.Rafiee Zadeh A, Ghadimi K, Mohammadi B, Hatamian H, Naghibi SN, Danaeiniya A. Effects of estrogen and progesterone on different immune cells related to multiple sclerosis. Casp J Neurol Sci. 2018;4:83–90. [Google Scholar]
- 7.Andreea GI, Pegza R, Lascu L, Bondari S, Stoica Z, Bondari A. The role of imaging techniques in diagnosis of breast cancer. Curr Health Sci J. 2011;37:241–248. [Google Scholar]
- 8.Allahverdipour H, Asghari-Jafarabadi M, Emami A. Breast cancer risk perception, benefits of and barriers to mammography adherence among a group of Iranian women. Women Health. 2011;51:204–219. doi: 10.1080/03630242.2011.564273. [DOI] [PubMed] [Google Scholar]
- 9.Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, Ebrahimi M. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13:383–91. doi: 10.1111/j.1524-4741.2007.00446.x. [DOI] [PubMed] [Google Scholar]
- 10.Koroltchouk V, Stanley K, Stjernswärd J. The control of breast cancer a World Health Organization perspective. Cancer. 1990;65:2803–2810. doi: 10.1002/1097-0142(19900615)65:12<2803::aid-cncr2820651233>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
- 11.Lima ZS, Ebadi MR, Amjad G, Younesi L. Application of imaging technologies in breast cancer detection: a review article. Open Access Maced J Med Sci. 2019;7:838. doi: 10.3889/oamjms.2019.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Forootan M, Tabatabaeefar M, Mosaffa N, Ashkalak HR, Darvishi M. Investigating esophageal stent-placement outcomes in patients with inoperable non-cervical esophageal cancer. J Cancer. 2018;9:213. doi: 10.7150/jca.21854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Safarpour Lima Z, Ebadi M, Amjad G, Younesi L. Application of imaging technologies in breast cancer detection: a review article. Open Access Maced J Med Sci. 2019;7:838–848. doi: 10.3889/oamjms.2019.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Fass L. Imaging and cancer: a review. Mol Oncol. 2008;2:115–152. doi: 10.1016/j.molonc.2008.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Cho N, Han W, Han BK, Bae MS, Ko ES, Nam SJ, Chae EY, Lee JW, Kim SH, Kang BJ. Breast cancer screening with mammography plus ultrasonography or magnetic resonance imaging in women 50 years or younger at diagnosis and treated with breast conservation therapy. JAMA Oncol. 2017;3:1495–1502. doi: 10.1001/jamaoncol.2017.1256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Menezes GL, Knuttel FM, Stehouwer BL, Pijnappel RM, van den Bosch MA. Magnetic resonance imaging in breast cancer: a literature review and future perspectives. World J Clin Oncol. 2014;5:61. doi: 10.5306/wjco.v5.i2.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Esserman LJ, Shieh Y, Park JW, Ozanne EM. A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert Rev Mol Diagn. 2007;7:533–44. doi: 10.1586/14737159.7.5.533. [DOI] [PubMed] [Google Scholar]
- 18.Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, Pisano ED, Jong RA, Evans WP, Morton MJ. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151–2163. doi: 10.1001/jama.299.18.2151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Zhi H, Ou B, Luo BM, Feng X, Wen YL, Yang HY. Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. J Med Ultrasound. 2007;26:807–815. doi: 10.7863/jum.2007.26.6.807. [DOI] [PubMed] [Google Scholar]
- 20.Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS. Screening for breast cancer. Radiol Clin North Am. 2017;55:1145–1162. doi: 10.1016/j.rcl.2017.06.004. [DOI] [PubMed] [Google Scholar]
- 21.Leichter I, Buchbinder S, Bamberger P, Novak B, Fields S, Lederman R. Quantitative characterization of mass lesions on digitized mammograms for computer-assisted diagnosis. Invest Radiol. 2000;35:366–72. doi: 10.1097/00004424-200006000-00005. [DOI] [PubMed] [Google Scholar]
- 22.Karellas A, Vedantham S. Breast cancer imaging: a perspective for the next decade. J Med Phys. 2008;35:4878–4897. doi: 10.1118/1.2986144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Nishikawa RM, Mawdsley GE, Fenster A, Yaffe MJ. Scanned-projection digital mammography. J Med Phys. 1987;14:717–727. doi: 10.1118/1.596147. [DOI] [PubMed] [Google Scholar]
- 24.Berman CG. Recent advances in breast-specific imaging. Cancer Control. 2007;14:338–349. doi: 10.1177/107327480701400404. [DOI] [PubMed] [Google Scholar]
- 25.Skaane P, Skjennald A. Screen-film mammography versus full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program-the Oslo II Study. Radiology. 2004;232:197–204. doi: 10.1148/radiol.2321031624. [DOI] [PubMed] [Google Scholar]
- 26.Obenauer S, Luftner-Nagel S, Von Heyden D, Munzel U, Baum F, Grabbe E. Screen film vs full-field digital mammography: image quality, detectability and characterization of lesions. Eur Radiol. 2002;12:1697–1702. doi: 10.1007/s00330-001-1269-y. [DOI] [PubMed] [Google Scholar]
- 27.Jong RA, Yaffe MJ, Skarpathiotakis M, Shumak RS, Danjoux NM, Gunesekara A, Plewes DB. Contrast-enhanced digital mammography: initial clinical experience. Radiology. 2003;228:842–850. doi: 10.1148/radiol.2283020961. [DOI] [PubMed] [Google Scholar]
- 28.Diekmann F, Bick U. Tomosynthesis and contrast-enhanced digital mammography: recent advances in digital mammography. Eur Radiol. 2007;17:3086–3092. doi: 10.1007/s00330-007-0715-x. [DOI] [PubMed] [Google Scholar]
- 29.Albert US, Altland H, Duda V, Engel J, Geraedts M, Heywang-Köbrunner S, Hölzel D, Kalbheim E, Koller M, König K. 2008 update of the guideline: early detection of breast cancer in Germany. J Cancer Res Clin Oncol. 2009;135:339–354. doi: 10.1007/s00432-008-0450-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Guo R, Lu G, Qin B, Fei B. Ultrasound imaging technologies for breast cancer detection and management: a review. Ultrasound Med Biol. 2018;44:37–70. doi: 10.1016/j.ultrasmedbio.2017.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.M Gharekhanloo F, Haseli MM, Torabian S. Value of ultrasound in the detection of benign and malignant breast diseases: a diagnostic accuracy study. Oman Med J. 2018;33:380. doi: 10.5001/omj.2018.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kubota K, Hisa N, Ogawa Y, Yoshida S. Evaluation of tissue harmonic imaging for breast tumors and axillary lymph nodes. Oncol Rep. 2002;9:1335–1338. [PubMed] [Google Scholar]
- 33.Bamber J, Cosgrove D, Dietrich C, Fromageau J, Bojunga J, Calliada F, Cantisani V, Correas JM, D’onofrio M, Drakonaki E. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: basic principles and technology. Ultraschall Med. 2013;34:169–184. doi: 10.1055/s-0033-1335205. [DOI] [PubMed] [Google Scholar]
- 34.Averkiou MA, Bruce MF, Powers JE, Sheeran PS, Burns PN. Imaging methods for ultrasound contrast agents. Ultrasound Med Biol. 2020;46:498–517. doi: 10.1016/j.ultrasmedbio.2019.11.004. [DOI] [PubMed] [Google Scholar]
- 35.Calliada F, Campani R, Bottinelli O, Bozzini A, Sommaruga MG. Ultrasound contrast agents: basic principles. Eur J Radiol. 1998;27(Suppl 2):S157–S160. doi: 10.1016/s0720-048x(98)00057-6. [DOI] [PubMed] [Google Scholar]
- 36.Jia WR, Chai WM, Tang L, Wang Y, Fei XC, Han BS, Chen M. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors. Eur J Radiol. 2014;83:1098–1105. doi: 10.1016/j.ejrad.2014.03.027. [DOI] [PubMed] [Google Scholar]
- 37.Fiordelisi MF, Cavaliere C, Auletta L, Basso L, Salvatore M. Magnetic resonance imaging for translational research in oncology. J Clin Med. 2019;8:1883. doi: 10.3390/jcm8111883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Haghighi F, Naseh G, Mohammadifard M, Abdollahi N. Comparison of mammography and ultrasonography findings with pathology results in patients with breast cancer in Birjand, Iran. Electron Physician. 2017;9:5494. doi: 10.19082/5494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Badu-Peprah A, Adu-Sarkodie Y. Accuracy of clinical diagnosis, mammography and ultrasonography in preoperative assessment of breast cancer. Ghana Med J. 2018;52:235–241. doi: 10.4314/gmj.v52i3.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Lee JM, Arao RF, Sprague BL, Kerlikowske K, Lehman CD, Smith RA, Henderson LM, Rauscher GH, Miglioretti DL. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Intern Med. 2019;179:658–67. doi: 10.1001/jamainternmed.2018.8372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Fiordelisi MF, Cavaliere C, Auletta L, Basso L, Salvatore M. Magnetic resonance imaging for translational research in oncology. J Clin Med. 2019;8:1883. doi: 10.3390/jcm8111883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Brindle K. Molecular imaging using magnetic resonance: new tools for the development of tumour therapy. Br J Radiol. 2003;76:S111–S117. doi: 10.1259/bjr/50577981. [DOI] [PubMed] [Google Scholar]
- 43.Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer. 2008;98:388–398. doi: 10.1038/sj.bjc.6604168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zeng Z, Amin A, Roy A, Pulliam NE, Karavites LC, Espino S, Helenowski I, Li X, Luo Y, Khan SA. Preoperative magnetic resonance imaging use and oncologic outcomes in premenopausal breast cancer patients. NPJ Breast Cancer. 2020;6:1–8. doi: 10.1038/s41523-020-00192-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89. doi: 10.3322/canjclin.57.2.75. [DOI] [PubMed] [Google Scholar]
- 46.Moloney BM, McAnena PF, Ryan ÉJ, Beirn EO, Waldron RM, Connell AO, Walsh S, Ennis R, Glynn C, Lowery AJ, McCarthy PA. The impact of preoperative breast magnetic resonance imaging on surgical management in symptomatic patients with invasive lobular carcinoma. Breast Cancer (Auckl) 2020;14:1178223420948477. doi: 10.1177/1178223420948477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A, Maringa M, Pfeifer U, Krebs D, Schild HH. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology. 2000;215:267–279. doi: 10.1148/radiology.215.1.r00ap01267. [DOI] [PubMed] [Google Scholar]
- 48.Warner E, Plewes D, Shumak R, Catzavelos G, Di Prospero L, Yaffe M, Goel V, Ramsay E, Chart P, Cole D. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J. Clin. Oncol. 2001;19:3524–3531. doi: 10.1200/JCO.2001.19.15.3524. [DOI] [PubMed] [Google Scholar]
- 49.Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, Ioffe OB. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–849. doi: 10.1148/radiol.2333031484. [DOI] [PubMed] [Google Scholar]
- 50.Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 2008;148:671–679. doi: 10.7326/0003-4819-148-9-200805060-00007. [DOI] [PubMed] [Google Scholar]
- 51.Sardanelli F, Podo F, Santoro F, Manoukian S, Bergonzi S, Trecate G, Vergnaghi D, Federico M, Cortesi L, Corcione S. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results. Invest Radiol. 2011;46:94–105. doi: 10.1097/RLI.0b013e3181f3fcdf. [DOI] [PubMed] [Google Scholar]
- 52.Lehman CD, Lee CI, Loving VA, Portillo MS, Peacock S, DeMartini WB. Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women 30-39 years of age. AJR Am J Roentgenol. 2012;199:1169–1177. doi: 10.2214/AJR.12.8842. [DOI] [PubMed] [Google Scholar]
- 53.Tan K, Mohamad ZA, Rumaisa M, Siti MAM, Radhika S, Nurismah M, Norlia A, Zulfiqar M. The comparative accuracy of ultrasound and mammography in the detection of breast cancer. Med J Malaysia. 2014;69:79–85. [PubMed] [Google Scholar]
- 54.Song SE, Seo BK, Cho KR, Woo OH, Son GS, Kim C, Cho SB, Kwon SS. Computer-aided detection (CAD) system for breast MRI in assessment of local tumor extent, nodal status, and multifocality of invasive breast cancers: preliminary study. Cancer Imaging. 2015;15:1. doi: 10.1186/s40644-015-0036-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Berg WA, Bandos AI, Mendelson EB, Lehrer D, Jong RA, Pisano ED. Ultrasound as the primary screening test for breast cancer: analysis from ACRIN 6666. J Natl Cancer Inst. 2016;108:djv367. doi: 10.1093/jnci/djv367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Omidiji OA, Campbell PC, Irurhe NK, Atalabi OM, Toyobo OO. Breast cancer screening in a resource poor country: ultrasound versus mammography. Ghana Med J. 2017;51:6–12. doi: 10.4314/gmj.v51i1.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
